Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Histopathology|June 14, 2021
Combined histopathological risk score using TP53 protein expression, CD8+ T cell density and intratumoral budding is an independent predictor of neoadjuvant therapy response in rectal adenocarcinomaWei Chen, Lama Farchoukh, Lindsey Seigh, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|February 18, 2020
Quantitative image analysis for CD8 score in lung small biopsies and cytology cell-blocksSara E Monaco, Sanja Dacic, Lindsey Seigh, et al.
Cancer Cytopathology|May 14, 2020
Ki-67 proliferation index in neuroendocrine tumors: Can augmented reality microscopy with image analysis improve scoring?Swati P Satturwar, Joshua L Pantanowitz, Christopher D Manko, et al.
Cancer Cytopathology|July 14, 2017
Critical diagnoses in cytopathology: Experience at a large medical centerJuan Xing, Lindsey Seigh, Sara E Monaco, et al.
The American Journal of Surgical Pathology|March 25, 2020
Automated Quantitation of CD8-positive T Cells Predicts Prognosis in Colonic Adenocarcinoma With Mucinous, Signet Ring Cell, or Medullary Differentiation Independent of Mismatch Repair Protein StatusDouglas J Hartman, Madison Frank, Lindsey Seigh, et al.
American Journal of Clinical Pathology|February 2, 2021
Artificial Intelligence-Based Screening for Mycobacteria in Whole-Slide Images of Tissue SamplesLiron Pantanowitz, Uno Wu, Lindsey Seigh, et al.
The Oncologist|April 24, 2024
Automated Quantitative CD8+ Tumor-Infiltrating Lymphocytes and Tumor Mutation Burden as Independent Biomarkers in Melanoma Patients Receiving Front-Line Anti-PD-1 ImmunotherapyDylan Fortman, Arivarasan Karunamurthy, Douglas Hartman, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|November 8, 2023
Implementation of Digital Image Analysis in Assessment of Ki67 Index in Breast CancerRachel K Vanderschelden, Jacob A Jerome, Daniel Gonzalez, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2025
Randomized Phase II Clinical Trial of Sulforaphane in Former Smokers at High Risk for Lung CancerJian-Min Yuan, Thomas W Kensler, Sanja Dacic, et al.
Clinical Epigenetics|January 7, 2022
Pembrolizumab plus azacitidine in patients with chemotherapy refractory metastatic colorectal cancer: a single-arm phase 2 trial and correlative biomarker analysisChaoyuan Kuang, Yongseok Park, Ryan C Augustin, et al.
Pageof 1